Nanomedicine based on chemotherapy-induced immunogenic death combined with immunotherapy to enhance antitumor immunity

IntroductionChemo-immunotherapy based on inducing tumor immunogenic cell death (ICD)with chemotherapy drugs has filled the gaps between traditional chemotherapy and immunotherapy. It is verified that paclitaxel (PTX) can induce breast tumor ICD. From this basis, a kind of nanoparticle that can effic...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yichang Chen, Kuirong Mao, Dongxiao Han, Ruolin Ma, Tianmeng Sun, Haipeng Zhang, Bing Han
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-12-01
Saila:	Frontiers in Pharmacology
Gaiak:	breast cancer tumor immunogenic cell death combination immunotherapy nanomedicine antitumor immunity
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1511423/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!